Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Festa

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Nature Communications|May 3, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetesRoderick C Slieker, Louise A Donnelly, Elina Akalestou, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Nature Communications|May 3, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetesRoderick C Slieker, Louise A Donnelly, Elina Akalestou, et al.
Pageof 5